View in EDS HTML Full Text PDF Full Text

No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.

Saved in:
Bibliographic Details
Title: No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.
Authors: Nguyen D; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Miao X; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Taskar K; GlaxoSmithKline, Ware, UK., Magee M; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Gorycki P; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Moore K; Allucent, Cary, North Carolina, USA., Tai G; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Aug; Vol. 12 (4), pp. e1238.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38988092
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nguyen+D%22">Nguyen D</searchLink>; GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Miao+X%22">Miao X</searchLink>; GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Taskar+K%22">Taskar K</searchLink>; GlaxoSmithKline, Ware, UK.<br /><searchLink fieldCode="AU" term="%22Magee+M%22">Magee M</searchLink>; GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gorycki+P%22">Gorycki P</searchLink>; GlaxoSmithKline, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Moore+K%22">Moore K</searchLink>; Allucent, Cary, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Tai+G%22">Tai G</searchLink>; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101626369%22">Pharmacology research & perspectives</searchLink> [Pharmacol Res Perspect] 2024 Aug; Vol. 12 (4), pp. e1238.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd%2C+British+Pharmacological+Society+and+American+Society+for+Pharmacology+and+Experimental+Therapeutics%22">John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101626369 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2052-1707 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220521707%22">20521707 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Res Perspect <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38988092
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/prp2.1238
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1238
    Titles:
      – TitleFull: No dose adjustment of metformin or substrates of organic cation transporters (OCT)1 and OCT2 and multidrug and toxin extrusion protein (MATE)1/2K with fostemsavir coadministration based on modeling approaches.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nguyen D
      – PersonEntity:
          Name:
            NameFull: Miao X
      – PersonEntity:
          Name:
            NameFull: Taskar K
      – PersonEntity:
          Name:
            NameFull: Magee M
      – PersonEntity:
          Name:
            NameFull: Gorycki P
      – PersonEntity:
          Name:
            NameFull: Moore K
      – PersonEntity:
          Name:
            NameFull: Tai G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2052-1707
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Pharmacology research & perspectives
              Type: main
ResultId 1